Comments
Loading...

Channel Therapeutics Stock News

CHROAMEX
Logo brought to you by Benzinga Data
$1.84
0.5946.61%
At close: -
$1.92
0.084.34%
After Hours: 7:59 PM EDT
Ligand Pharmaceuticals (LGND) announced it will be merged with Channel Therapeutics (CHRO) on Thursday, April 17, 2025

Latest Channel Therapeutics Stock News | AMEX:CHRO | Benzinga

Get the latest news on Channel Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Channel Therapeutics performance

Thursday, April 17, 2025